The diagnostic value of sural nerve T cells in chronic inflammatory demyelinating polyneuropathy

Neurology

Volumn 53, Issue 4, 1999, Pages 837-845

  Bosboom, W M J ^b   Van Den Berg, L H ^a   De Boer, L ^b   Van Son, M J ^b   Veldman, H ^b   Franssen, H ^b   Logtenberg, T ^b   Wokke, J H J ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Sural nerve; T cell

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC DISEASE; CLINICAL ARTICLE; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DISEASE SEVERITY; ELECTROPHYSIOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPHOCYTIC INFILTRATION; MALE; NERVE BIOPSY; POLYNEUROPATHY; PRIORITY JOURNAL; SEX DIFFERENCE; SURAL NERVE;

EID: 0033547018     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.53.4.837     Document Type: Article

References (39)

1. Prineas JW, McLeod JG. Chronic relapsing polyneuritis. J Neurol Sci 1976;27:427-458.
2. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy: a clinical and electrophysiological study of 92 cases. Brain 1987;110:1617-1630.
3. Barohn RJ, Kissel JT, Warmolts JR, Mendell JR. Chronic inflammatory demyelinating polyradiculoneuropathy: clinical characteristics, course, and recommendations for diagnostic criteria. Arch Neurol 1989;46:878-884.
4. Dyck PJ, Prineas JW, Pollard JD. Chronic inflammatory demyelinating polyradiculopathy. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, eds. Peripheral neuropathy. 3rd ed. Philadelphia: W.B. Saunders, 1993:1498-1517.
5. Dalakas MC, Engel WK. Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol 1981; 9(suppl):134-145.
6. Hughes RAC. Inflammatory neuropathies. Baillieres Clin Neurol 1994;3:45-72.
7. Toyka KV, Hartung HP. Chronic inflammatory polyneuritis and related neuropathies. Curr Opin Neurol 1996;9:240-250.
8. Hartung HP, Toyka KV, Griffin JW. Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. In: Antel J, Birnbaum G, Hartung HP, eds. Clinical neuroimmunology. Blackwell Science, 1998:294-306.
9. Van der Meche FGA, Van Doom PA. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol 1995;37(suppl 1):S14-S31.
10. Hughes RAC, Atkinson P, Coates P, Hall S, Leibowitz S. Sural nerve biopsies in Guillain-Barré syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 1992;15:568-575.
11. Koski CL. Immune interactions in the peripheral nervous system. In: Latov N, Wokke JHJ, Kelly JJ Jr, eds. Immunological and infectious diseases of the peripheral nerves. Cambridge: Cambridge University Press, 1998:3-28.
12. Griffin JW, George R, Ho T. Macrophage systems in peripheral nerves: a review. J Neuropathol Exp Neurol 1993;52:553-560.
13. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 1998;121:469-479.
14. Taylor WA, Hughes RAC. T lymphocyte activation antigens in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy. J Neuroimmunol 1989;24:33-39.
15. Van den Berg LH, Mollee I, Wokke JHJ, Logtenberg T. Increased frequencies of HPRT mutant T lymphocytes in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: further evidence for a role of T cells in the etiopathogenesis of peripheral demyelinating diseases. J Neuroimmunol 1995;58:37-42.
16. Hartung HP, Hughes RAC, Taylor WA, Heininger K, Reiners K, Toyka KV. T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors. Neurology 1990;40:215-218.
17. Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG. Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 1986;13:123-134.
18. Krendel DA, Parks HP, Anthony DC, St.Clair MB, Graham DG. Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1989;12:257-264.
19. Cornblath DR, Griffin DE, Welch D, Griffin JW, McArthur JC. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 1990;26:113-118.
20. Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci 1994;127:170-178.
21. Oka N, Akiguchi I, Nagao M, Nishio T, Kawasaki T, Kimura J. Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy. Neurology 1994;44:946-950.
22. Stewart JD, McKelvey R, Durcan L, Carpenter S, Karpati G. Chronic inflammatory demyelinating polyneuropathy (CIDP) in diabetics. J Neurol Sci 1996;142:59-64.
23. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barré syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 1996;19:474-487.
24. Schroder HD, Olsson T, Solders G, Kristensson K, Link H. HLA-DR-expressing cells and T-lymphocytes in sural nerve biopsies. Muscle Nerve 1988;11:864-870.
25. Gabreëls-Festen AAWM, Gabreëls FJM, Hoogendijk JE, Bolhuis PA, Jongen PJH, Vingerhoets HM. Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria. Acta Neuropathol (Berl) 1993;86:630-635.
26. Kerkhoff H, Troost D, Louwerse ES, van Dijk M, Veldman H, Jennekens FGI. Inflammatory cells in the peripheral nervous system in motor neuron disease. Acta Neuropathol (Berl) 1993;85:560-565.
27. Younger DS, Rosoklija G, Hays AP, Trojaborg W, Latov N. Diabetic peripheral neuropathy: a clinicopathologic and immunohistochemical analysis of sural nerve biopsies. Muscle Nerve 1996;19:722-727.
28. Cornblath DR, Asbury AK, Albers JW, et al. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP): report from an ad hoc subcommittee of the American Academy of Neurology AIDS Task Force. Neurology 1991;41:617-618.
29. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke 1988;19:604-607.
30. Notermans NC, Wokke JHJ, Franssen H, et al. Chronic idiopathic polyneuropathy presenting in middle or old age: a clinical and electrophysiological study of 75 patients. J Neurol Neurosurg Psychiatry 1993;56:1066-1071.
31. Notermans NC, Wokke JHJ, van der Graaf Y, Franssen H, van Dijk GW, Jennekens FG. Chronic idiopathic axonal polyneuropathy: a five-year follow-up. J Neurol Neurosurg Psychiatry 1994;57:1525-1527.
32. Said G. Vasculitic neuropathy. Baillieres Clin Neurol 1995;4: 489-503.
33. Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain 1996;119:1441-1448.
34. Van den Berg LH, Franssen H, Wokke JHJ. Improvement of multifocal motor neuropathy during long-term weekly treatment with human immunoglobulin. Neurology 1995;45:987-988.
35. Stoll G. Immunocytochemistry as a diagnostic tool. Baillieres Clin Neurol 1996;5:129-142.
36. Engelhardt A, Lorler H, Neundorfer B. Immunohistochemical findings in vasculitic neuropathies. Acta Neurol Scand 1993; 87:318-321.
37. Griffin JW, Stoll G, Li CY, Tyor W, Cornblath DR. Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 1990;27(suppl):S64-S68.
38. Olsson T, Sun JB, Solders G, et al. Autoreactive T and B cell responses to myelin antigens after diagnostic sural nerve biopsy. J Neurol Sci 1993;117:130-139.
39. Molenaar DSM, Vermeulen M, de Haan R. Diagnostic value of sural nerve biopsy in chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 1998;64: 84-89.